2018 AHA/ACC/AACVPR/AAPA/ ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the man- agement of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e1082 143. 144. Andersson C, Enserro D, Larson MG, et al. Implications of the US choles- terol guidelines on eligibility for statin therapy in the community: com- parison of observed and predicted risks in the Framingham Heart Study Offspring Cohort. J Am Heart Assoc. 2015;4:e001888. 145. Colantonio LD, Richman JS, Carson AP, et al. Performance of the ath- erosclerotic cardiovascular disease pooled cohort risk equations by social deprivation status. J Am Heart Assoc. 2017;6:e005676. 18 146. Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guide- line on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(suppl 2):S49 73. 147. Mora S, Wenger NK, Cook NR, et al. Evaluation of the pooled cohort risk equations for cardiovascular risk prediction in a multiethnic cohort from the Women s Health Initiative. JAMA Intern Med. 2018;178:1231 40. 148. Jung KJ, Jang Y, Oh DJ, et al. The ACC/AHA 2013 pooled cohort equa- tions compared to a Korean Risk Prediction Model for atherosclerotic cardiovascular disease. Atherosclerosis. 2015;242:367 75. 149. Yang X, Li J, Hu D, et al. Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR Project (Prediction for ASCVD Risk in China). Circulation. 2016;134:1430 40. 150. Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease pre- vention in a European cohort. JAMA. 2014;311:1416 23. 151. Pylypchuk R, Wells S, Kerr A, et al. 